AI-Developed Vaccine First Human Trial at Cambridge: Targeting All Coronaviruses
Researchers at the University of Cambridge have commenced the first human clinical trial of a vaccine component designed entirely by artificial intelligence. The trial evaluates a vaccine conceived to provide ... Read More